1 week Ago By [email protected] (MENAFN)
Competition and Regional Market Analysis Key players in the market are Exact Science, Labcorp Genetics Inc., Blueprint Genetics, Ambry Genetics, Genex Diagnostics Inc., Sonic Healthcare, Dante Labs US, Myriad Genetics, Inc.
, Revvity, Laboratory Corporation of America Holdings, BGI Group, and Fulgent Genetics. North America holds the largest share in the genetic screening testing for preventive health market, primarily driven by technological advancements, robust healthcare infrastructure, and high consumer awareness. The U.
S., in particular, is a key player due to its well-established healthcare system, extensive research on genetic testing, and a growing focus on personalized medicine. Additionally, the availability of direct-to-consumer genetic testing companies, such as 23andMe, has increased market penetration.
Europe is also a major market for genetic screening, with countries like the United Kingdom, Germany, and France investing heavily in preventive healthcare. The European market is characterized by a high demand for genetic tests related to cancer, cardiovascular diseases, and neurological conditions. The region benefits from strong healthcare policies that encourage genetic testing.
The Asia-Pacific region has been experiencing significant growth in the genetic screening testing for preventive health market, driven by increasing healthcare awareness, rising incomes, and growing investment in healthcare infrastructure. Countries such as China, India, Japan, and South Korea are emerging as key markets for genetic testing. While India and China have large populations with diverse genetic profiles, Japan and South Korea are leading the way in terms of advanced healthcare technologies.
The Middle East and Africa region presents emerging opportunities for genetic screening, with growing interest in healthcare advancements and genetic testing. The UAE, Saudi Arabia, and South Africa are leading the region's adoption of preventive health measures, including genetic screenings, although economic and infrastructure barriers persist in some areas. Key Topics Covered 1.
Global Genetic Screening Testing for Preventive Health Market Overview 1.1 Market Outlook 1.1.
1 Definitions 1.1.2 Inclusion and Exclusion Criteria 1.
1.3 Market Size, 2024-2035 (US$) 1.1.
4 Market Growth Scenario 1.1.4.
1 Realistic Scenario 1.1.4.
2 Optimistic Scenario 1.1.4.
3 Pessimistic Scenario 1.2 Industry Outlook 1.2.
1 Market Overview 1.2.2 Market Ecosystem 1.
2.3 Key Trends 1.2.
4 Opportunity Assessment 1.2.5 Regulatory Landscape 1.
2.6 Reimbursement Scenario 1.3 Market Dynamics 1.
3.1 Market Opportunities and Trends 1.3.
2 Market Drivers 1.3.2.
1 Impact Analysis 1.3.3 Market Restraints 1.
3.3.1 Impact Analysis 1.
3.4 Market Challenges 1.3.
4.1 Impact Analysis 2. Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by Test Type 2.
1 Presymptomatic and Predictive testing 2.2 Carrier Screening Test 2.2.
1 Expanded Carrier Screening 2.2.2 Targeted Carrier Screening 2.
3 Non-Invasive Prenatal Test 2.4 Preimplantation Genetic Testing (PGT) 2.5 Newborn Screening 3.
Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by Technology 3.1 Next Generation Sequencing (NGS) 3.2 Microarray 3.
3 FISH 3.4 PCR 3.5 Others 4.
Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by Application 4.1 Oncology 4.2 Cardiovascular Disease 4.
3 Reproductive Health 4.4 Neurodegenerative diseases 4.5 Rare Disease 4.
6 Others 5. Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by End User 5.1 Hospitals 5.
2 Clinics 5.3 Direct to Consumer (DTC) 5.4 Others 6.
Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by Geography 6.1 Market Overview 6.1.
1 Market Dynamics 6.1.2 Market Size and Forecast 6.
1.2.1 North America Genetic Screening Testing for Preventive Health Market 6.
1.2.2 Europe Genetic Screening Testing for Preventive Health Market 6.
1.2.3 Asia Pacific Genetic Screening Testing for Preventive Health Market 6.
1.2.4 Latin America Genetic Screening Testing for Preventive Health Market 6.
1.2.5 Middle East and Africa Genetic Screening Testing for Preventive Health Market 7.
Global Genetic Screening Testing for Preventive Health Market - Competitive Benchmarking and Company Profiles 7.1 Competitive Benchmarking 7.2 Competitive Landscape 7.
2.1 Key Strategies and Developments by Company 7.2.
1.1 Funding Activities 7.2.
1.2 Mergers and Acquisitions 7.2.
1.3 Regulatory Approvals 7.2.
1.4 Partnerships, Collaborations, and Business Expansions 7.2.
2 Key Developments Analysis 7.3 Company Profiles 7.3.
1 Exact Science 7.3.1.
1 Company Overview 7.3.1.
2 Product Portfolio/Offering 7.3.1.
3 Key Competitors 7.3.1.
4 Target Customers/End Users 7.3.1.
5 Analyst View 7.3.2 Labcorp Genetics Inc.
7.3.3 Blueprint Genetics 7.
3.4 Ambry Genetics 7.3.
5 Genex Diagnostics Inc. 7.3.
6 Sonic Healthcare 7.3.7 Dante Labs US 7.
3.8 Myriad Genetics, Inc. 7.
3.9 Revvity 7.3.
10 Laboratory Corporation of America Holdings 7.3.11 23andMe 7.
3.12 BGI Group 7.3.
13 CENTOGENE N.V. 7.
3.14 Fulgent Genetics. 7.
3.15 Quest Diagnostics Incorporated. 7.
3.16 Progenesis 7.3.
17 CooperSurgical 7.3.18 Illumina 7.
3.19 Igenomix 7.3.
20 Agilent Technologies, Inc. 7.3.
21 Other Key Companies For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. MENAFN11042025004107003653ID1109417952 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind.
We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above..
